跳至主要内容
临床试验/NCT01173302
NCT01173302Unknown4 期

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Peking University People's Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
4 期
入组人数
160
试验地点
1
主要终点
Rabies antibody titer

研究概览

简要总结

This study is to investigate the persistence of rabies Chinese manufactured antibody 1-5 years after the post-exposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose. A total of 160 subjects would be enrolled. These subjects were all administered ChengDa antirabies vaccine from 2005 to 2009. After informed consent is obtained, these subjects would be tested for their antirabies antibody titer and given a single booster dose. Seven and 14 days later, the investigators would re-evaluate the antibody titer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 20 to 60 years old
  • Given ChengDa rabies vaccine
  • Good compliance
  • Obtained informed consent

排除标准

  • Other than inclusion criteria

结局指标

主要结局

Rabies antibody titer

时间窗: 6 months

We test the antirabies antibody titer before and after the single booster dose

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验